MAM
BBC launches first marketing campaign in West Bank
MUMBAI: The BBC has launched its first ever marketing campaign across the West Bank, promoting the availability of BBC Arabic on partner station, Radio Bethlehem 2000, 89.6 FM.
The strapline running throughout the three-month-long jointly branded campaign is BBC Arabic on Radio Bethlehem 2000 – together we enrich your world. The advertising campaign, featuring two hands cupping a globe that focusses on the Middle East can be seen on billboards in high-profile areas in Jerusalem, Ramallah and Bethlehem.
West Bank commuters can also see the campaign on buses branded with the design and in advertisements placed in Al Quds newspaper. Radio Bethlehem 2000 listeners can hear BBC programming 12 hours a day in Arabic and English.
BBC Arabic head Hosam El Sokkari said, “Our partnership with Radio Bethlehem 2000 is an important addition to the BBC’s FM presence in the Arab world. With this campaign, even more people in the West Bank will be aware of the availability of the BBC programmes, in Arabic and English, in crystal clear quality, and our listener base in this region will further expand.”
Yousef Shomali, Head of Radio Bethlehem 2000, added, “The partnership with the BBC represents an important phase in the growth and development of Radio Bethlehem 2000. By airing the BBC Arabic programming, we hope to help our listeners in Bethlehem, Jerusalem and the West Bank to benefit from the output of the world’s leading broadcaster.
“This campaign will send a clear, positive message to all Arab-speakers, particularly those who are interested in the international agenda.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
